Research Article
Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Table 1
Phakic patients: descriptive statistics.
| Group I age | Group II age | value | Number of patients | Group I | Group II | |
| 58.24 years ± 9.24 years | 56.32 ± 11.1 years | 0.48 | N = patients | 56 | 49 | |
| Parameter | Preoperative value | value | Postoperative values | value | Group I | Group II | Group I | Group II |
| IOP (mm Hg) | 30.5 ± 4.0 | 29.3 ± 3.11 | 0.87 | 15.34 ± 2.34 | 14.10 ± 3.20 | 0.58 | CDVA (logMAR) | 0.48 ± 0.31 | 0.42 ± 0.24 | 0.72 | 0.44 ± 0.25 | 0.40 ± 0.26 | 0.42 | Diurnal IOP | 4.47 ± 2.32 | 3.50 ± 1.40 | 0.77 | 2.13 ± 0.89 | 1.72 ± 0.5 | 0.56 | Number of medications | 3.22 ± 1.1 | 3.10 ± 1.48 | 0.85 | 0.11 ± 0.04 | 0.12 ± 0.03 | 0.54 | Duration of medicine use | 6.35 ± 4.25 years | 4.56 ± 5.23 years | 0.32 | | | |
|
|
Group I: 24 males and 32 females; Group II: 29 males and 20 females. |